Susquehanna International Group, LLP Xeris Biopharma Holdings, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.06 - $2.96 $28,634 - $41,144	13,900 Added 36.77%	51,700 $147,000
Q2 2024 Aug 15, 2024	BUY	$1.7 - $2.45 $27,030 - $38,955	15,900 Added 72.6%	37,800 $85,000
Q1 2024 May 07, 2024	SELL	$2.04 - $3.22 $219,096 - $345,828	-107,400 Reduced 83.06%	21,900 $48,000
Q4 2023 Feb 14, 2024	SELL	$1.47 - $2.36 $68,061 - $109,268	-46,300 Reduced 26.37%	129,300 $303,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $2.69 $14,760 - $22,058	8,200 Added 4.9%	175,600 $326,000
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $218,764 - $358,196	120,200 Added 254.66%	167,400 $438,000
Q1 2023 May 16, 2023	SELL	$1.03 - $1.63 $237,312 - $375,552	-230,400 Reduced 83.0%	47,200 $76,000
Q4 2022 Feb 14, 2023	BUY	$1.14 - $1.65 $15,161 - $21,945	13,300 Added 5.03%	277,600 $369,000
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $248,929 - $350,681	-181,700 Reduced 40.74%	264,300 $412,000
Q2 2022 Aug 15, 2022	SELL	$1.48 - $2.64 $80,068 - $142,824	-54,100 Reduced 10.82%	446,000 $687,000
Q1 2022 May 16, 2022	BUY	$2.0 - $2.87 $853,800 - $1.23 Million	426,900 Added 583.2%	500,100 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$1.8 - $2.93 $131,760 - $214,476	73,200 New	73,200 $214,000

141

59.9M

148K

45.7K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $397M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.